Faeth Therapeutics FTH
NASDAQ FTH
$39.00 +2.88 (+7.97%)
As of: Sep 10, 2026 · 3:59 PM EDT

Faeth Therapeutics (FTH) Preferred Dividend Payments (2020)

Faeth Therapeutics' (FTH) quarterly Preferred Dividend Payments came in at $104000.0 in Q1 2020.

Analysis

Faeth Therapeutics (FTH) Preferred Dividend Payments (2020) Analysis & Trends

Faeth Therapeutics (FTH) has reported Preferred Dividend Payments for 1 consecutive years, with $104000.0 the latest figure, recorded in Q1 2020.

  • For the quarter ending Q1 2020, Preferred Dividend Payments changed N/A year-over-year to $104000.0; the trailing twelve-month figure through Dec 2020 stood at $104000.0 (changed N/A YoY), and the FY2020 full-year result was $104000.0, changed N/A from the prior year.
  • Preferred Dividend Payments was little changed at $104000.0 in Q1 2020 per FTH's latest filing.
  • Across five years, Preferred Dividend Payments topped out at $104000.0 in Q1 2020 and bottomed at $104000.0 in Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Faeth Therapeutics 218.99 Mn 218.99 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 104,000.00